Terms: = Bone cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884
129 results:
1. Network pharmacology and experimental validation to study the potential mechanism of Tongguanteng injection in regulating apoptosis in osteosarcoma.
Wei L; Meng J; Xiang D; Yang Q; Zhou Y; Xu L; Wang M; Chen J; Han Y
BMC Complement Med Ther; 2024 Jan; 24(1):67. PubMed ID: 38297292
[TBL] [Abstract] [Full Text] [Related]
2. Exploration of anti‑osteosarcoma activity of asiatic acid based on network pharmacology and
Pang H; Wu H; Zhan Z; Wu T; Xiang M; Wang Z; Song L; Wei B
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186298
[TBL] [Abstract] [Full Text] [Related]
3. A newly identified 45-kDa JAK2 variant with an altered kinase domain structure represents a novel mode of JAK2 kinase inhibitor resistance.
Gorantla SP; Mueller TA; Albers-Leischner C; Rudelius M; von Bubnoff N; Duyster J
Mol Oncol; 2024 Feb; 18(2):415-430. PubMed ID: 38104968
[TBL] [Abstract] [Full Text] [Related]
4. The anti-oncogenic effect of 17-DMAG via the inactivation of hsp90 and MET pathway in osteosarcoma cells.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Kubota Y; Tsumura H
Oncol Res; 2023; 31(5):631-643. PubMed ID: 37547755
[TBL] [Abstract] [Full Text] [Related]
5. Identification and validation of a novel overall survival prediction model for immune-related genes in bone metastases of prostate cancer.
Bi W; Guo W; Fan G; Xie L; Jiang C
Aging (Albany NY); 2023 Jul; 15(14):7161-7186. PubMed ID: 37494663
[TBL] [Abstract] [Full Text] [Related]
6. Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells.
Carter BZ; Mak PY; Muftuoglu M; Tao W; Ke B; Pei J; Bedoy AD; Ostermann LB; Nishida Y; Isgandarova S; Sobieski M; Nguyen N; Powell RT; Martinez-Moczygemba M; Stephan C; Basyal M; Pemmaraju N; Boettcher S; Ebert BL; Shpall EJ; Wallner B; Morgan RA; Karras GI; Moll UM; Andreeff M
Blood; 2023 Sep; 142(12):1056-1070. PubMed ID: 37339579
[TBL] [Abstract] [Full Text] [Related]
7. Design, Synthesis, and Biological Evaluation of Androgen Receptor (AR) Antagonist-Heat Shock Protein 90 (hsp90) Inhibitor Conjugates for Targeted Therapy of Castration-Resistant Prostate cancer.
Zhang S; Meng X; Zhang S; Li B; Jin W; Zhang C; Liu Z; Hu X; Ge L; Yu Z; Li Z; Ma S; Wang X; Li L; Qin C
J Med Chem; 2023 Apr; 66(7):4784-4801. PubMed ID: 36960664
[TBL] [Abstract] [Full Text] [Related]
8. Human γδ T cells induce CD8
Wang S; Li H; Chen T; Zhou H; Zhang W; Lin N; Yu X; Lou Y; Li B; Yinwang E; Wang Z; Wang K; Xue Y; Qu H; Lin P; Sun H; Teng W; Mou H; Chai X; Cai Z; Ye Z
Cancer Immunol Immunother; 2023 Jun; 72(6):1803-1821. PubMed ID: 36680568
[TBL] [Abstract] [Full Text] [Related]
9. Optimisation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as novel hsp90 C-terminal domain inhibitors against Ewing sarcoma.
Zajec Ž; Dernovšek J; Distel M; Gobec M; Tomašič T
Bioorg Chem; 2023 Feb; 131():106311. PubMed ID: 36495678
[TBL] [Abstract] [Full Text] [Related]
10. Effects of cancer-associated point mutations on the structure, function, and stability of isocitrate dehydrogenase 2.
Chen X; Yang P; Qiao Y; Ye F; Wang Z; Xu M; Han X; Song L; Wu Y; Ou WB
Sci Rep; 2022 Nov; 12(1):18830. PubMed ID: 36335201
[TBL] [Abstract] [Full Text] [Related]
11. FOXO3a-dependent up-regulation of hsp90 alleviates cisplatin-induced apoptosis by activating FUNDC1-mediated mitophagy in hypoxic osteosarcoma cells.
Lu D; Liu R; Zhou Y; Zhang Z; Jiang X; Xu J; Su A; Hu Z
Cell Signal; 2023 Jan; 101():110500. PubMed ID: 36270475
[TBL] [Abstract] [Full Text] [Related]
12. Proteasomal deubiquitylase activity enhances cell surface recycling of the epidermal growth factor receptor in non-small cell lung cancer.
Wang S; Wang T; Yang Q; Cheng S; Liu F; Yang G; Wang F; Wang R; Yang D; Zhou M; Duan C; Zhang Y; Liu H; Dai Z; Tian K; Liu S
Cell Oncol (Dordr); 2022 Oct; 45(5):951-965. PubMed ID: 36129611
[TBL] [Abstract] [Full Text] [Related]
13. Mebendazole's Conformational Space and Its Predicted Binding to Human Heat-Shock Protein 90.
Fiedler W; Freisleben F; Wellbrock J; Kirschner KN
J Chem Inf Model; 2022 Aug; 62(15):3604-3617. PubMed ID: 35867562
[TBL] [Abstract] [Full Text] [Related]
14. Aberrant hsp90 Expression in Lymphocytes and hsp90 Response to Anti-PD-1 Therapy in Lymphoma Patients.
Albakova Z; Mangasarova Y; Albakov A; Nikulina E; Kravchenko S; Sapozhnikov A
Front Immunol; 2022; 13():893137. PubMed ID: 35572591
[TBL] [Abstract] [Full Text] [Related]
15. secDrug: a pipeline to discover novel drug combinations to kill drug-resistant multiple myeloma cells using a greedy set cover algorithm and single-cell multi-omics.
Kumar H; Mazumder S; Chakravarti S; Sharma N; Mukherjee UK; Kumar S; Baughn LB; Van Ness BG; Mitra AK
Blood Cancer J; 2022 Mar; 12(3):39. PubMed ID: 35264575
[TBL] [Abstract] [Full Text] [Related]
16. Canine osteosarcoma cells exhibit basal accumulation of multiple chaperone proteins and are sensitive to small molecule inhibitors of GRP78 and heat shock protein function.
Mattos DR; Weinman MA; Wan X; Goodall CP; Serrill JD; McPhail KL; Milovancev M; Bracha S; Ishmael JE
Cell Stress Chaperones; 2022 May; 27(3):223-239. PubMed ID: 35244890
[TBL] [Abstract] [Full Text] [Related]
17. Toll-like Receptor 4, Osteoblasts and Leukemogenesis; the Lesson from Acute Myeloid Leukemia.
Bruserud Ø; Reikvam H; Brenner AK
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163998
[TBL] [Abstract] [Full Text] [Related]
18. The Expression of the RUVBL1 Component of the R2TP Complex Correlates with Poor Prognosis in DLBCL.
Lone M; Shadang M; Akhter Q; Kumar M; Mallick S; Gogia A; Nilima N; Chauhan SS; Mir RA
Pathobiology; 2022; 89(3):146-156. PubMed ID: 35078195
[TBL] [Abstract] [Full Text] [Related]
19. Advances in the role of heat shock protein 90 in prostate cancer.
Fu Z; Jia B
Andrologia; 2022 May; 54(4):e14376. PubMed ID: 35075667
[TBL] [Abstract] [Full Text] [Related]
20. Network Pharmacology Prediction: The Possible Mechanisms of Cinobufotalin against Osteosarcoma.
Chen R; Guan Z; Zhong X; Zhang W; Zhang Y
Comput Math Methods Med; 2022; 2022():3197402. PubMed ID: 35069780
[TBL] [Abstract] [Full Text] [Related]
[Next]
